← brief for 2026-09-27 · Transplant & xeno
Transplant and immunosuppression eligibility restrictions in phase III systemic-therapy trials for renal cell and urothelial carcinoma: a registry–protocol meta-research study
Key takeaways
This study looks at cancer trial rules. It checks if people with transplants are allowed to join. There are no new results on how the drugs work. It is a look at who is allowed in the studies.
Who did this work
D.S. Akhmetov · Ilshat Smolinov · Oraz Sayat
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-26
https://doi.org/10.17605/osf.io/jca23